Business Wire

FOURKITES

23.8.2022 10:18:11 CEST | Business Wire | Press release

Share
3T-FourKites Partnership Offers Enhanced Cost and Sustainability Benefits to Customers

Leading real-time supply chain visibility platform FourKites ® today announces that its carrier data will be used to enhance 3T’s global digital transport platform.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005400/en/

The deal will give 3T’s shipper customers access to FourKites’ supply chain visibility data, bringing them powerful flexibility in the way they use carriers, thereby reducing costs and improving sustainability initiatives.

“FourKites’ broad coverage of carriers in Europe allows us to give our customers a more comprehensive shipment visibility offering as part of our digital transport management software,” says Rob Hutton, Group Sales and Marketing Director at 3T. “That gives them more flexibility in the carriers they can work with, keeping both costs and carbon emissions down.”

3T is a UK-based global SaaS digital transport platform provider, whose transport management solutions dovetail neatly with FourKites’ supply chain visibility offering. 3T’s pioneering cloud-based platform provides a seamless shipper/carrier ecosystem with functionality including transport assignment, rate management and tendering, as well as automatic carrier allocation. It also facilitates supply chain collaboration by enabling AI-driven dynamic planning and execution across multiple accounts, harnessing real-time data to reduce empty running of vehicles.

FourKites is the market leader in real-time, end-to-end supply chain visibility, extending visibility beyond transportation into yards, warehouses, stores and more. The companies’ combined offering signals a paradigm shift in 3T’s ability to not only know the status and position of every shipment, but to also dynamically react to changes from plan.

“Giving 3T customers access to FourKites data will allow them to make better decisions, optimising the way they use carriers,” says Marc Boileau, Senior VP of Sales and Carrier Operations at FourKites Europe. “That has cost benefits for them, it improves their service to customers with almost no administrative work required, and it gives them the most accurate estimated times of arrival available in the market today. We are thrilled to be working together with the 3T team to better support their customer base.”

Carbon reductions

3T already gives customers multiple options to capture carrier data. However, with the addition of FourKites’ real-time supply chain data, 3T customers will now have all the data necessary to complete their operational visibility picture and ultimately help them reduce both carbon emissions and costs through improved resource utilisation.

“We see a huge efficiency opportunity for both shippers and carriers by using data to identify and reduce empty running across the industry. This will be essential to meet our collective environmental targets,” says Rob, "and it’s why this partnership is so exciting for us.”

This is just one aspect of the improved planning shippers can achieve with the 3T-FourKites partnership.

“You’re likely to get a good price by placing a shipment on an empty running truck,” says Marc, “so costs go down. But carriers have fewer empty runs, too, so they see driver productivity improve. It’s win-win. The better your visibility, the better you can plan to optimise your transport.”

In March, FourKites announced its Sustainability Hub, which offers granular emissions tracking, industry benchmarks, analytics and scenario modeling to help customers meet sustainability goals. In addition, the company offers Dynamic Yard ® , a new category of software that connects traditional, siloed yard management software with FourKites’ real-time supply chain data and predictive ETAs to provide insight into driver detention patterns, labor efficiency and more to reduce dwell and inform carbon reduction strategies. Last year, customers who used Dynamic Yard emitted 20% fewer carbon emissions than non-Dynamic Yard users through reductions in truck idle times.

Notes for editors

About FourKites®

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit www.fourkites.com .

About 3T

3T Logistics and Technology Group is an award-winning UK head-quartered SaaS transport management technology business with clients including JCB, Klockner Pentaplast and Kraft Heinz. Founded in 2000 as a 4th Party Logistics Provider (4PL), 3T has evolved to become a globally recognised transportation management (TMS) technology provider. The company’s vision and mission remain the same since its inception, to improve service, reduce cost to shippers and carriers and remove empty running through collaboration and the smart use of technology.

To learn more about 3T please visit their website: https://www.3t-ltg.com/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release

Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release

IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release

Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye